BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomasoni D, Adamo M, Lombardi CM, Metra M. Highlights in heart failure. ESC Heart Fail 2019;6:1105-27. [PMID: 31997538 DOI: 10.1002/ehf2.12555] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Pagnesi M, Adamo M, Sama IE, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Lang CC, Ng LL, Ponikowski P, Ravera A, Samani NJ, Zannad F, van Veldhuisen DJ, Voors AA, Metra M. Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. Eur J Heart Fail 2021. [PMID: 34164895 DOI: 10.1002/ejhf.2276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cao G, Fan C, Liu Y, Huang H, Li J, Liang J, Tao B, Yuan J. A telehealth program benefits discharged patients with heart failure. Acta Cardiol 2022;:1-8. [PMID: 34979861 DOI: 10.1080/00015385.2021.1999571] [Reference Citation Analysis]
3 Li X, Zhang Q, Zhu L, Wang G, Ge P, Hu A, Sun X. Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials. Int J Cardiol 2021;332:119-26. [PMID: 33838152 DOI: 10.1016/j.ijcard.2021.03.077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ziebolz D, Binner C, Reuschel F, Eisner M, Wagner J, Kottmann T, Etz CD, Lehmann S, Garbade J, Schmalz G. Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy. BMC Cardiovasc Disord 2021;21:304. [PMID: 34134635 DOI: 10.1186/s12872-021-02111-5] [Reference Citation Analysis]
5 Wu B, Zhang Z, Long J, Zhao H, Zeng F. Association between lipoprotein (a) and heart failure with reduced ejection fraction development. J Clin Lab Anal 2021;:e24083. [PMID: 34850462 DOI: 10.1002/jcla.24083] [Reference Citation Analysis]
6 Tomasoni D, Lombardi CM, Sbolli M, Cotter G, Metra M. Acute heart failure: More questions than answers. Prog Cardiovasc Dis 2020;63:599-606. [PMID: 32283133 DOI: 10.1016/j.pcad.2020.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hadzibegovic S, Sikorski P, Potthoff SK, Springer J, Lena A, Anker MS. Clinical problems of patients with cachexia due to chronic illness: a congress report. ESC Heart Fail 2020. [PMID: 33012131 DOI: 10.1002/ehf2.13052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Fu D, Zhou J, Xu S, Tu J, Cai Y, Liu J, Cai Z, Wang D. Smilax glabra Roxb. flavonoids protect against pathological cardiac hypertrophy by inhibiting the Raf/MEK/ERK pathway: In vivo and in vitro studies. J Ethnopharmacol 2022;292:115213. [PMID: 35331878 DOI: 10.1016/j.jep.2022.115213] [Reference Citation Analysis]
9 Mezzaroma E, Abbate A, Toldo S. The inflammasome in heart failure. Curr Opin Physiol 2021;19:105-12. [PMID: 34917871 DOI: 10.1016/j.cophys.2020.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hua J, Wang C, Kong Q, Zhang Y, Wang Q, Xiong Z, Hu J, Li J, Chen Q, Hong K. Comparative effects of left bundle branch area pacing, His bundle pacing, biventricular pacing in patients requiring cardiac resynchronization therapy: A network meta-analysis. Clin Cardiol 2022. [PMID: 35128691 DOI: 10.1002/clc.23784] [Reference Citation Analysis]
11 Kamon D, Sugawara Y, Soeda T, Okamura A, Nakada Y, Hashimoto Y, Ueda T, Nishida T, Onoue K, Okayama S, Watanabe M, Kawakami R, Saito Y. Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction. ESC Heart Fail 2021;8:317-25. [PMID: 33295115 DOI: 10.1002/ehf2.13070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhao K, Li Y, Zhou Z, Mao Y, Wu X, Hua D, Yong Y, Li P. Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation. European Journal of Pharmacology 2022;923:174932. [DOI: 10.1016/j.ejphar.2022.174932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Giallauria F, Cuomo G, Parlato A, Raval NY, Kuschyk J, Stewart Coats AJ. A comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life. ESC Heart Fail 2020;7:2922-32. [PMID: 32700809 DOI: 10.1002/ehf2.12902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Haba MȘC, Șerban DN, Șerban L, Tudorancea IM, Haba RM, Mitu O, Iliescu R, Tudorancea I. Nanomaterial-Based Drug Targeted Therapy for Cardiovascular Diseases: Ischemic Heart Failure and Atherosclerosis. Crystals 2021;11:1172. [DOI: 10.3390/cryst11101172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Turan B, Durak A, Olgar Y, Tuncay E. Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction. Mol Cell Biochem. [DOI: 10.1007/s11010-022-04474-5] [Reference Citation Analysis]
16 Sierpiński R, Sokolska JM, Suchocki T, Koń B, Urbański F, Kruk M, Sokolski M, Ponikowski P, Jankowska EA. 10 year trends in hospitalization rates due to heart failure and related in-hospital mortality in Poland (2010-2019). ESC Heart Fail 2020. [PMID: 33089965 DOI: 10.1002/ehf2.13060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Feng XH, Wang Y, Wang LY, Shen JF, You CY, Feng QT. Value of PTEN and Echocardiography in Predicting the Efficacy of Trimetazidine Combined with Metoprolol in the Treatment of Heart Failure. Int J Gen Med 2021;14:10257-63. [PMID: 34992440 DOI: 10.2147/IJGM.S346538] [Reference Citation Analysis]
18 Li X, Li D, Cui X, Zhou K, Liu J, Fan Z, Lu J, Wan J, Yan R, Xia J, Li X, Wu Y, Lin Q, Li Y, Wang Y. A Single-Central, Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial Protocol: A Clinical Effect Evaluation Study on the TCM Comprehensive Intervention Program for Chronic Heart Failure. Evidence-Based Complementary and Alternative Medicine 2021;2021:1-7. [DOI: 10.1155/2021/4577139] [Reference Citation Analysis]
19 Jin G, Wang L, Ma J. Inhibiting STAT5 significantly attenuated Ang II-induced cardiac dysfunction and inflammation. Eur J Pharmacol 2022;915:174689. [PMID: 34919891 DOI: 10.1016/j.ejphar.2021.174689] [Reference Citation Analysis]
20 Wang T, Tian J, Jin Y. VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium. Sci Rep 2021;11:19488. [PMID: 34593936 DOI: 10.1038/s41598-021-98998-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sax DR, Rana JS, Mark DG, Huang J, Collins SP, Liu D, Storrow AB, Reed ME; KP CREST Network. Outcomes among acute heart failure emergency department patients by preserved vs. reduced ejection fraction. ESC Heart Fail 2021;8:2889-98. [PMID: 33978311 DOI: 10.1002/ehf2.13364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Gortan Cappellari G, Aleksova A, Dal Ferro M, Cannatà A, Semolic A, Zanetti M, Springer J, Anker SD, Giacca M, Sinagra G, Barazzoni R. Preserved Skeletal Muscle Mitochondrial Function, Redox State, Inflammation and Mass in Obese Mice with Chronic Heart Failure. Nutrients 2020;12:E3393. [PMID: 33158222 DOI: 10.3390/nu12113393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Liu Y, Yin Z, Xu X, Liu C, Duan X, Song Q, Tuo Y, Wang C, Yang J, Yin S. Crosstalk between the activated Slit2-Robo1 pathway and TGF-β1 signalling promotes cardiac fibrosis. ESC Heart Fail 2021;8:447-60. [PMID: 33236535 DOI: 10.1002/ehf2.13095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Giri Ravindran S, Kakarla M, Ausaja Gambo M, Yousri Salama M, Haidar Ismail N, Tavalla P, Uppal P, Mohammed SA, Rajashekar S, Hamid P. The Effects of Sodium-Glucose Cotransporter-2 Inhibitors (SLGT-2i) on Cardiovascular and Renal Outcomes in Non-diabetic Patients: A Systematic Review. Cureus. [DOI: 10.7759/cureus.25476] [Reference Citation Analysis]
25 Yin D, Qiu M, Wei X, Duan X. Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials. Medicine (Baltimore) 2021;100:e26561. [PMID: 34260534 DOI: 10.1097/MD.0000000000026561] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Reina-couto M, Silva-pereira C, Pereira-terra P, Quelhas-santos J, Bessa J, Serrão P, Afonso J, Martins S, Dias CC, Morato M, Guimarães JT, Roncon-albuquerque R, Paiva J, Albino-teixeira A, Sousa T. Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target. Front Physiol 2022;13:965611. [DOI: 10.3389/fphys.2022.965611] [Reference Citation Analysis]
27 Domengé O, Ragot H, Deloux R, Crépet A, Revet G, Boitard SE, Simon A, Mougenot N, David L, Delair T, Montembault A, Agbulut O. Efficacy of epicardial implantation of acellular chitosan hydrogels in ischemic and nonischemic heart failure: impact of the acetylation degree of chitosan. Acta Biomater 2021;119:125-39. [PMID: 33161185 DOI: 10.1016/j.actbio.2020.10.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front Physiol 2021;12:746494. [PMID: 34707513 DOI: 10.3389/fphys.2021.746494] [Reference Citation Analysis]
29 Zhao P, Wang Y, Zhang L, Zhang J, Liu N, Wang H. Mechanism of long non‑coding RNA metastasis‑associated lung adenocarcinoma transcript 1 in lipid metabolism and inflammation in heart failure. Int J Mol Med 2021;47:5. [PMID: 33448307 DOI: 10.3892/ijmm.2020.4838] [Reference Citation Analysis]
30 Wang Y, Zhang J, Wang Z, Wang C, Ma D. Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction. Heart Fail Rev 2022. [PMID: 35266091 DOI: 10.1007/s10741-022-10224-y] [Reference Citation Analysis]
31 Jiang X, Shao M, Liu X, Liu X, Zhang X, Wang Y, Yin K, Wang S, Hu Y, Jose PA, Zhou Z, Xu FJ, Yang Z. Reversible Treatment of Pressure Overload-Induced Left Ventricular Hypertrophy through Drd5 Nucleic Acid Delivery Mediated by Functional Polyaminoglycoside. Adv Sci (Weinh) 2021;8:2003706. [PMID: 33717857 DOI: 10.1002/advs.202003706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Lombardi CM, Cimino G, Pagnesi M, Dell'Aquila A, Tomasoni D, Ravera A, Inciardi R, Carubelli V, Vizzardi E, Nodari S, Emdin M, Aimo A. Vericiguat for Heart Failure with Reduced Ejection Fraction. Curr Cardiol Rep 2021;23:144. [PMID: 34410527 DOI: 10.1007/s11886-021-01580-6] [Reference Citation Analysis]
33 Cheang I, Liao S, Zhu Q, Ni G, Wei C, Jia Z, Wu Y, Li X. Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum. Front Pharmacol 2022;13:867521. [PMID: 35370696 DOI: 10.3389/fphar.2022.867521] [Reference Citation Analysis]
34 Liu J, Hu J, Tan L, Zhou Q, Wu X. Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats. BMC Cardiovasc Disord 2021;21:403. [PMID: 34418957 DOI: 10.1186/s12872-021-02209-w] [Reference Citation Analysis]
35 Arfsten H, Goliasch G, Bartko PE, Prausmüller S, Spinka G, Cho A, Novak J, Mascherbauer J, Haslacher H, Strunk G, Hülsmann M, Pavo N. Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure. ESC Heart Fail 2021;8:2016-24. [PMID: 33742565 DOI: 10.1002/ehf2.13278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Lena A, Anker MS, Springer J. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science. Int J Mol Sci 2020;21:E6549. [PMID: 32911600 DOI: 10.3390/ijms21186549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
37 Ma CY, Ma YQ, Deng M. Mechanism of Zhen Wu Decoction in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med 2022;2022:4877920. [PMID: 35341142 DOI: 10.1155/2022/4877920] [Reference Citation Analysis]
38 Piña IL, Allen LA, Desai NR. Policy and Payment Challenges in the Postpandemic Treatment of Heart Failure: Value-Based Care and Telehealth. J Card Fail 2021:S1071-9164(21)00360-2. [PMID: 34520854 DOI: 10.1016/j.cardfail.2021.08.019] [Reference Citation Analysis]
39 Yeh JN, Yue Y, Chu YC, Huang CR, Yang CC, Chiang JY, Yip HK, Guo J. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity. Biomed Pharmacother 2021;144:112244. [PMID: 34601193 DOI: 10.1016/j.biopha.2021.112244] [Reference Citation Analysis]
40 Yang K, Xue Y, Yu M, Jiao H, Li Y, Wei X, Liu W, Sun Y, Chen N, Song L, Yu T, Chen K, Guo D, Song Z. Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/2387860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Patoulias D, Papadopoulos C, Kassimis G, Boulmpou A, Karagiannis A, Doumas M. Updated Meta-Analysis Evaluating the Beneficial Effects of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure. Am J Cardiol 2021;161:118-20. [PMID: 34794611 DOI: 10.1016/j.amjcard.2021.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bielecka-Dabrowa A, Ebner N, Dos Santos MR, Ishida J, Hasenfuss G, von Haehling S. Cachexia, muscle wasting, and frailty in cardiovascular disease. Eur J Heart Fail 2020;22:2314-26. [PMID: 32949422 DOI: 10.1002/ejhf.2011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
43 Zhang T, Ge J. Mechanism of CREB1 in cardiac function of rats with heart failure via regulating the microRNA-376a-3p/TRAF6 axis. Mamm Genome 2022. [PMID: 35217880 DOI: 10.1007/s00335-022-09947-y] [Reference Citation Analysis]